Saúde Pública
Estudo randomizado por cluster | Um programa multifatorial para prevenção de quedas nas casas de repouso do Reino Unido reduziu os índices de queda entre idosos e foi custo-efetivo.
21 Jan, 2022 | 15:23hComunicado de imprensa: Falls in care homes can be significantly reduced with intervention, says new study – University of Nottingham
Comentário no Twitter
NEW RESEARCH: A falls prevention programme for older people in care homes, co-designed with care home staff & residents, that involved awareness raising, education, screening, decision & implementation support was associated with a reduction in falls rate https://t.co/wupI0LeAxj
— The BMJ (@bmj_latest) December 11, 2021
Análise sistemática | Impacto global da resistência bacteriana a antibióticos em 2019.
20 Jan, 2022 | 23:06hGlobal burden of bacterial antimicrobial resistance in 2019: a systematic analysis – The Lancet
Comunicado de imprensa: An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections, more deaths than HIV/AIDS or malaria – The Lancet
Editorial: Antimicrobial resistance: time to repurpose the Global Fund – The Lancet
Comentário: Antimicrobial resistance now a leading cause of death worldwide, study finds – The Guardian
Comentário no Twitter
NEW—An estimated 1.2 million people died in 2019 from antibiotic-resistant bacterial infections, more deaths than HIV/AIDS or malaria.#GRAMPaper reveals the scale of antimicrobial resistance (#AMR), now a leading cause of death worldwide: https://t.co/2h5UEKemEq #AMRSOS pic.twitter.com/aWLhmdirJ8
— The Lancet (@TheLancet) January 20, 2022
Estudo de modelo sugere que 1,8 milhão de mortes em excesso podem ser atribuíveis a poluição do ar nas cidades em 2019.
20 Jan, 2022 | 23:04hComunicado de imprensa: The Lancet Planetary Health: 1.8 million excess deaths attributable to urban air pollution in 2019, modelling study suggests
Estudos relacionados:
Comentário no Twitter (fio – clique para saber mais)
NEW—Approx. 86% of people living in urban areas exposed to unhealthy particulate matter levels, leading to 1.8 million excess deaths in 2019: modelling study in @TheLancetPlanet. #AirPollutionhttps://t.co/kw34ANZ4ph
Thread 🧵 pic.twitter.com/QiRXU4QVHP
— The Lancet (@TheLancet) January 6, 2022
Impactos global, regional e nacional da osteoartrite de quadril de 1990 a 2019: estimativas do 2019 Global Burden of Disease Study.
20 Jan, 2022 | 20:51hGrandes desafios na saúde oftálmica global: processo de priorização global usando o método Delphi.
20 Jan, 2022 | 20:38hPodcast relacionado: Author interview
Comentário no Twitter
Roughly 2.2 billion people have vision impairment—yet 50% of sight loss is preventable.
In @LancetLongevity, Jacqueline Ramke & colleagues identify the key issues that must be addressed to improve global #EyeHealth in the context of an ageing population.https://t.co/banTov24VX pic.twitter.com/tLSZaUYXhw
— The Lancet (@TheLancet) January 6, 2022
Impactos global, regional e nacional de 12 distúrbios mentais em 204 países e territórios, 1990–2019: análise sistemática para o Global Burden of Disease Study 2019.
13 Jan, 2022 | 21:08hComentário convidado: The true global disease burden of mental illness: still elusive – The Lancet Psychiatry (necessário cadastro gratuito)
Estimativa de prevalência global de demência em 2019 e prevalência prevista para 2050: uma análise do Global Burden of Disease Study 2019.
12 Jan, 2022 | 12:52hComunicado de imprensa: Global dementia cases set to triple by 2050 unless countries address risk factors – The Lancet
Comentários:
Forecasting the prevalence of dementia – The Lancet Public Health
Dementia cases expected to almost triple across the world by 2050 – BBC
Number of adults with dementia to exceed 150m by 2050, study finds – The Guardian
Comentário no Twitter (fio – clique para saber mais)
🆕✨First #GBDstudy forecasts global #dementia cases set to triple by 2050 (up from 57m in 2019 to expected 153m people) unless countries address risk factors: #smoking, #obesity, #HighBloodSugar, & low #education🧵👇
Published in @TheLancet @TheLancetPHhttps://t.co/GccTPRroEV
— Institute for Health Metrics and Evaluation (IHME) (@IHME_UW) January 7, 2022
Incidência de mortalidade, anos de vida perdidos e anos vividos com incapacidade para 29 grupos de câncer de 2010 a 2019: análise sistemática para o Global Burden of Disease Study 2019.
12 Jan, 2022 | 12:47hComunicado de imprensa: Cancer deaths rose to 10 million worldwide in 2019: Recent trends also highlight global disparities in cancer burden – Institute for Health Metrics and Evaluation
Nova diretriz AAP recomenda o rastreamento de rotina para HIV para todos os jovens de 15 anos ou mais.
10 Jan, 2022 | 12:20hComentário: Pediatricians Can Play Key Role in HIV Testing, Prophylaxis – HealthDay
Estudo randomizado | Tratamento antirretroviral de baixo custo e de fácil adesão, baseado em dolutegravir, como terapia de primeira ou segunda linha foi não inferior ao tratamento padrão da infecção por HIV-1 em crianças.
10 Jan, 2022 | 12:13hDolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentário: Easy-to-take medicine better at suppressing HIV in children – University College London
Comentários no Twitter
Dolutegravir-based antiretroviral therapy was compared with standard care in children and adolescents starting first- or second-line therapy for HIV type 1 infection. Dolutegravir-based ART was superior to standard-care ART. https://t.co/PP0XaEVswO pic.twitter.com/pQvhjdXcUk
— NEJM (@NEJM) December 29, 2021
Visual Abstract: Dolutegravir as First- or Second-Line HIV Treatment in Children https://t.co/2RIg9uH2V1 pic.twitter.com/mDr1Z6l6CJ
— NEJM (@NEJM) January 4, 2022